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Background: S100C (S100A11) is a member of the S100 calcium-binding
protein family, the function of which is not yet entirely clear, but may include
cytoskeleton assembly and dynamics. S100 proteins consist of two EF-hand
calcium-binding motifs, connected by a flexible loop. Like several other
members of the family, S100C forms a homodimer. A number of S100 proteins
form complexes with annexins, another family of calcium-binding proteins that
also bind to phospholipids. Structural studies have been undertaken to
understand the basis of these interactions.
Results: We have solved the crystal structure of a complex of calcium-loaded
S100C with a synthetic peptide that corresponds to the first 14 residues of
the annexin I N terminus at 2.3 Å resolution. We find a stoichiometry of one
peptide per S100C monomer, the entire complex structure consisting of two
peptides per S100C dimer. Each peptide, however, interacts with both
monomers of the S100C dimer. The two S100C molecules of the dimer are
linked by a disulphide bridge. The structure is surprisingly close to that of the
p11—annexin II N-terminal peptide complex solved previously. We have
performed competition experiments to try to understand the specificity of the
S100—annexin interaction.
Conclusions: By solving the structure of a second annexin N terminus—S100
protein complex, we confirmed a novel mode of interaction of S100 proteins with
their target peptides; there is a one-to-one stoichiometry, where the dimeric
structure of the S100 protein is, nevertheless, essential for complex formation.
Our structure can provide a model for a Ca2+-regulated annexin I−S100C
heterotetramer, possibly involved in crosslinking membrane surfaces or
organising membranes during certain fusion events.
Introduction
The transient increase of intracellular Ca2+ concentration
is a signalling event, which can be transduced by proteins
whose activities are modulated by Ca2+ binding [1]. Ca2+
allows proteins such as annexins to bind to negatively
charged phospholipids [2] and it can induce large confor-
mational changes in EF-hand proteins, rendering them
capable of binding to their targets [3,4]. S100 proteins are
small proteins with an average molecular mass of 10kDa,
and are formed mainly by a pair of EF hands [5–8].
Whereas calmodulin is a ubiquitously expressed member
of the EF-hand superfamily, different members of the
S100 subfamily of EF-hand proteins are often expressed in
a tissue-specific manner [9]. Some S100 proteins are over-
expressed in certain conditions such as Alzheimer’s
disease or Down’s syndrome [10]. The precise functions of
S100 proteins are not known, although they are reported to
be involved in a variety of processes such as the regulation
of protein phosphorylation by various kinases (e.g., protein
kinase C and casein kinase II-α), regulation of enzyme
activities (fructose aldolase, glycogen phosphorylase,
myosin-associated giant kinase twitchin, adenylate cyclase,
guanylate cyclase and cytosolic phospholipase A2), and the
regulation of cytoskeleton dynamics. Other functions of
S100 proteins appear to be associated with extracellular
pools, for example as a neurite extension factor or a
chemotactic activity for leucocytes [8]. In addition, a
number of targets of S100 proteins have been identified
and often several targets have been described for one
single S100 protein; S100B, for example, binds to τ pro-
teins [11], p53 [12,13] and CapZ [14,15], as well as to some
metabolic enzymes ([16]; reviewed in [6,8]). Several inter-
actions between members of the annexin family and S100
proteins have been characterised. One example is the
binding of p11 (S100A10) to annexin II, which increases
the affinity of annexin II for Ca2+. Further support for the
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regulatory role of complex formation is given by the fact
that the heterotetramer (annexin II)2−(p11)2, but not
monomeric annexin II, is important for membrane junc-
tion formation and vesicular aggregation [17,18]. Other
S100 proteins that can bind to annexins are calcyclin
(S100A6), which interacts with annexin XI [19], and S100C
(S100A11), which binds annexin I [20–22].
S100C (S100A11) was first identified in chicken gizzard and
was termed calgizzarin [23]. It may be involved in smooth
muscle activity. In keratinocytes, it has been shown,
together with p11 and annexin I, to be required for the for-
mation of cornified envelopes [24], which correlates with a
transglutaminase crosslink at the plasma membrane [25].
S100C is closely related to p11 but, whereas the latter has
lost its capability to bind Ca2+ by mutations in both of its EF
hands, S100C can bind Ca2+, a requirement for its associa-
tion with annexin I [22]. The precise functions of annexin I
are not known but it is thought to be involved in some
membrane transport processes [26], possibly in the later
steps of endocytic receptor uptake [27]. Annexin I is partly
localised on endosomes and this localisation also targets
S100C to endocytic organelles [28]. It is the N-terminal
region of annexin I, including the N-acetylation of the first
residue, that is necessary for binding to S100C [22]. We
report here the crystal structure of the complex between
calcium-bound S100C and an N-acetylated peptide corre-
sponding to the first 14 amino acids of annexin I. 
S100 proteins, with the exception of calbindin D9k [29],
tend to form dimers. It has therefore been suggested [30,31]
that an S100 dimer will bind one target peptide rather like
calmodulin (a protein containing four EF hands). Our struc-
ture of the S100C−annexin I peptide, as well as our earlier
structure of p11 with the annexin II N-terminal peptide
[32], shows that the stoichiometry of binding corresponds,
in fact, to two peptides per S100 dimer. 
Our paper describes the structure of the S100C−annexin I
N-terminal peptide complex formed in the presence of
calcium, which was determined at 2.3 Å resolution by
X-ray crystallography. This structure is very close to that
of the p11−annexin II N-terminal peptide complex we
had determined earlier [32], confirming a more general
pattern of interaction of S100 proteins with their peptide
targets. The stoichiometry of binding corresponds to one
peptide per S100 monomer, with the peptides lying on the
periphery of the complex, each one interacting with both
molecules of the S100 protein dimer. Finally, a disulphide
bridge linking the two molecules in the dimer via Cys11
residues was found in our structure.
Results and discussion
S100C structure
The structure of the S100C complex with the annexin I
N-terminal peptide was solved by X-ray crystallography to
2.3 Å resolution (Table 1). The rather high average B
value of 42.9 Å2 is most likely due to a high solvent
content (68.2%). The electron density was well defined
for the entire S100C molecule except in the N-terminal
region, where the first three amino acids could not be
traced in the electron-density map.
The S100C monomer is formed by a pair of EF hand,
helix-loop-helix, motifs (HI–L1–HII and HIII–L3–HIV)
linked by a flexible loop (L2) and maintained side-by-
side by a short antiparallel β sheet (Figure 1a). S100C is
in the holo form, with Ca2+ ions in both EF hands. In the
N-terminal EF hand, Ca2+ is coordinated by peptide car-
bonyls of residues Ala23, Asp26, Asn28 and Lys31, the
bidentate carboxylic group of Glu36 and a water mol-
ecule. In the C-terminal EF hand, Ca2+ is coordinated by
monodentate carboxylic groups of Asp66, Asp68 and
Asp70, the peptide carbonyl group of Gln72, the biden-
tate carboxylic group of Glu77 and a water molecule. In
both cases, the geometry of the ligands is a pentagonal
bipyramid. The S100C backbone is very close to those of
holo S100B [31] (root mean square [rms] = 1.045 Å) and
of apo p11 [32] (rms = 1.030 Å). Thus, S100C with
calcium bound (holo S100C) is in an open form in which
the two helices of the C-terminal EF hand have probably
moved upon Ca2+ binding. In the calcyclin and S100B
apo forms [33,34], helices HIII and HIV are nearly parallel,
whereas in the holo form they are perpendicular to each
other [31]. This conformational change creates a cleft
between HIV and the linker region L2. In our structure L2
is not well defined, with the highest B values, indicating
that this region is flexible. Nevertheless, L2 is in an
α-helical conformation in S100C, as shown in the 
p11−peptide complex [32].
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Table 1
Crystallographic data.
Resolution (Å) 20−2.3
Observations 61,772
Unique 9310
Data completion 0.997
Rmerge 0.08
I/σ(I) 2.3 in the last resolution shell
Refinement
R 0.214
Rfree 0.268
No. atoms 841
Water molecules 23
<B> (Å2) 42.9
Rms bonds 0.017 Å
Rms angles 1.6°
Rms planes 0.01 Å
Ramachandran majority 89.4%
Ramachandran additional 10.6%
Rmerge = ΣhΣi I(h)i – <I(h)>]/ ΣhΣi(I(h)i. R = ΣFo −Fc/ΣFo, Rfree is
defined in [57], 10% exclusion was used. ‘Ramachandran’: the
percentage of peptide bonds in the most favoured and the additional
region of the Ramachandran plot (determined by PROCHECK [58]).
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Although there is only one molecule in the asymmetric
unit, a dimer of S100C is formed with a symmetry-related
molecule. The S100C dimer generated by the twofold
crystallographic axis is similar to S100 dimers described for
holo S100B and for p11 [31,32,35]. Dimerisation is
achieved by antiparallel interactions between N-terminal
and C-terminal helices of both monomers. 
Disulphide bridge
An intermolecular disulphide bridge was found between
two Cys11 residues related by crystallographic symmetry
(Figure 1b). Because a crystallographic twofold axis passes
through the cysteine residue, refinement was not per-
formed, yet the disulphide bridge shows a typical left-
hand conformation. This disulphide bridge crosslinks the
S100C dimer and does not lead to the formation of multi-
mers of higher molecular weight. It has been hypothesised
that the S100C dimer could be linked by a disulphide
bridge [23], but no other observation in vivo or in vitro has
been reported. 
Disulphide bridge formation in S100 proteins and their
physiological relevance is still unclear. A covalent dimer of
S100B containing a disulphide bridge at Cys84 has been
shown to be essential for the neurite extension factor
(NEF) activity of the protein [36–38] and cysteine oxida-
tion of S100B leads to changes in phosphorylation by
casein kinase CKII-α [39]. The cysteines involved in the
NEF structure, however, have not yet been characterised.
Other disulphides have been reported to occur in calcyclin
in vitro but were interpreted as storage artefacts [40].
Recent structural determinations of S100 proteins have
shown that disulphides could also be observed in the
crystal. An intramolecular disulphide bridge was found in
psoriasin [30], whereas a different intermolecular disul-
phide bridge, reported in p11, leads to the formation of a
p11 tetramer [32]. S100 proteins do have a conserved cys-
teine in the C-terminal helix but the disulphides reported
involve specific cysteine residues found at different, non-
conserved positions. For instance, psoriasin lacks the con-
served cysteine in the C-terminal helix and the
intramolecular disulphide bridge is formed between a cys-
teine in loop L2 and a cysteine downstream from the con-
served position in the C-terminal helix. In the case of p11
[32], the disulphide bridge involves the specific cysteine
residue at position 61. This cysteine residue, within the
C-terminal EF hand, is present only in p11, S100B and
S100E. The cysteine residue involved in S100C crosslink-
ing is conserved in all S100C sequences determined so far.
It lies on the twofold axis of the non-covalent dimer and is
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Figure 1
Schematic representation of the S100C
structure. (a) The S100C monomer (helices in
red and loops in yellow) with the calcium ions
and coordinating residues shown in detail.
(b) The S100C dimer (in yellow and blue).
The disulphide bridge is in yellow and the
peptides in green, the calcium ions are shown
as red balls. The figure was generated using
MOLSCRIPT [59].
st8205.qxd  03/01/2000  02:30  Page 177
in a very favourable situation to form an intermolecular
disulphide bridge because the SH groups of the two mol-
ecules are at the right distance. This disulphide could thus
form easily under non-reducing conditions. This property
could be important for structural functions of S100C as a
component of the cornified envelope.
Protein−peptide interactions
The annexin I N-terminal peptide is clearly visible in the
complex, despite its high temperature factor (Figure 2).
Although the stoichiometry is one peptide bound to one
S100C monomer, the binding zone on S100C is formed by
regions of both molecules of the dimer: the C-terminal
helix and the L2 linker region of one molecule and the 
N-terminal helix of the other molecule. The peptide
forms an amphiphilic α helix, as predicted [20]. Most of
the hydrophobic residues of the peptide are buried in the
complex essentially in contact with the C-terminal helix of
S100C, whereas the hydrophilic residues of the peptide
are involved in hydrogen bonding with the N-terminal
helix of S100C. Glu9 of S100C forms a hydrogen bond
with Ser4 of the peptide and Glu13 of S100C forms hydro-
gen bonds with the backbone of the peptide involving car-
bonyls at positions 2 and 3.
Mutation studies have identified residues in the C-termi-
nal extension of S100C, especially those between Asp91
and Ile94, as crucial for target protein (annexin I) binding
[22]. Indeed, the structure shows residues Ser92 and
Phe93 as partially buried in the complex interface. More-
over, biochemical experiments including chemical cross-
linking and analytical gel filtration revealed that
dimerisation is not compromised in S100C mutant pro-
teins lacking residues 91–99 [22]. Our structure shows that
although residues 93, 94 and 98 in the C-terminal exten-
sion participate in mediating dimer contacts, their contri-
bution is less strong than that of hydrophobic residues
further upstream (i.e. between positions 75 and 90). Thus,
it appears that the C-terminal residues, although providing
dimer contacts in the crystals, are not absolutely essential
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Figure 2
The electron density for the annexin I
N-terminal peptide with the structure of the
peptide superimposed.
Figure 3
Superposition of the annexin II (purple) and
annexin I (yellow) peptides in complex with p11
(cyan) and S100C (blue), respectively. The
figure was generated using MOLSCRIPT [59].
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for dimer stability. The C-terminal truncation of both mol-
ecules in the dimer, however, seems to reduce the
hydrophobic surface of the peptide-binding site enough to
prevent complex formation. 
The experiments of Seemann et al. [22] were carried out
in the presence of dithiothreitol (DTT) as a reducing
agent. This could explain why a disulphide-linked dimer
was not observed. In other experiments identifying
S100C as the ligand of annexin I [20], it was found that
both a 10 kDa full-length S100C and a 6 kDa proteolytic
fragment of S100C lacking the C-terminal extension
could bind to annexin I. These results appear to be con-
tradictory to our structure; however, they could be
explained by the formation of a heterodimer between the
10 kDa and 6 kDa molecules stabilised by a disulphide
bridge, with at least one intact peptide-binding site
retained for each heterodimer.
Dimeric S100 proteins are indeed four-EF-hand structures
and thus could mimic other proteins containing four EF
hands, such as calmodulin. The peptide recognition by
S100 proteins is, however, rather different from that
observed in calmodulin. It has been suggested that an
S100 dimer could bind to only one target peptide in a
calmodulin-like manner, where the EF hands would wrap
around the peptide [30,31]. Our structure, in which two
peptides are bound to the surface of the S100C dimer,
shows clearly that this is not the case. Whereas the
peptide occupies an internal position in calmodulin−
peptide complexes, the peptides are peripheral in 
S100−peptide complexes. 
Peptide N-acetylation
The N-acetyl group of the peptide is not involved in con-
tacts with the S100C protein. The carbonyl of the acetyl
group is, however, involved in a hydrogen bond with the
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Figure 4
Titration of S100C and p11 with synthetic peptides. (a,b) 1 µM
Prodan-labelled Ac1–14 was mixed with different amounts of (a) p11
and (b) S100C and corresponding fluorescence emission spectra
were recorded after excitation at 392 nm. As described previously
[56], the Prodan-labelled peptide shows a characteristic fluorescence
increase and a significant blue shift of the fluorescence maximum upon
addition of p11 (a). Even an eightfold molar excess of S100C does not
cause a significant alteration of the peptide−Prodan emission spectrum
(b). (c,d) 10 µM Ac1–18 was mixed with different amounts of (c)
S100C and (d) p11 and the corresponding emission spectra were
recorded after excitation of the peptide tryptophan at 295 nm. In the
presence of S100C the peptide tryptophan shows a fluorescence
emission increase and a blue shift as described previously [22] (c).
These changes, which are indicative of binding, are not observed in the
case of p11 whose presence induces a non-specific decrease in
emission intensity (d). 
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amino group at position 4 of the peptide. This acetylation
has been shown to be essential for peptide recognition by
S100C; both recombinant annexin I which is not N-acety-
lated in Escherichia coli and non-acetylated peptides
derived from the annexin I N-terminal sequence do not
bind to S100C [41]. We suggest that the N-acetyl group
may stabilise the helical conformation of the isolated
peptide. In the study by Mailliard et al. [20], S100C was
identified as the ligand of annexin I with a construct con-
taining the N-terminal part of annexin I fused to the
C terminus of glutathione-S-transferase (GST). In this
fusion protein the N terminus of annexin I is not necessar-
ily acetylated and is extended by the GST sequence. Yet
binding is not disturbed by this extension, possibly
because it induces helix formation in the N-terminal
peptide of annexin I and thus has the same effect as
N-acetylation. It seems, therefore, that it is the correct
folding of the N-terminal part of annexin I into an α helix
that is necessary for its binding to S100C.
Comparison with the p11−annexin II peptide complex
The S100C−annexin I peptide complex is strikingly similar
to the p11−annexin II peptide complex [32]. In both cases
the peptides are located in exactly the same position
(Figure 3): when the p11 and S100C structures are super-
imposed, the rms difference between the peptide Cα is
only 0.85 Å. This finding is not entirely unexpected as p11
and S100C are closely related and may bind their target in
the same manner. What is interesting, though, is that the
annexin I and annexin II peptides have no sequence simi-
larities and the p11 and S100C sequences are rather dis-
similar in their N-terminal and C-terminal helices. Yet, the
entire complexes can be superimposed with very small dif-
ferences on Cα coordinates (rms difference of 0.87 Å). The
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Figure 5
Titration of preformed S100−peptide complexes with the non-cognate
peptide. (a,b) A mixture of Prodan-labelled Ac1–14 and p11 was
titrated with (a) the N-terminally acetylated (Ac1–18) or (b) the
unmodified (N1–18) peptide corresponding to residues 1–18 of the
annexin I molecule. No red shift and only a minor decrease of Prodan
fluorescence are observed when increasing amounts of Ac1–18 are
added (a). A similar analysis with the N1–18 peptide, which is inactive
in S100C binding [22], gives identical results confirming the inability of
the Ac1–18 peptide to compete the Ac1–14−p11 interaction (b).
(c,d) A mixture of Ac1–18 and S100C was titrated with (c) the
N-terminally acetylated (Ac1–14) or (d) the unmodified (N1–14)
annexin II peptide. The tryptophan emission spectra obtained in the
presence of the p11-binding competent (Ac1–14) or p11-binding-
incompetent (N1–14) annexin II peptide [56] are comparable and give
no indication of an interaction between S100C and Ac1–14, compare
parts (a) and (b).
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hydrophobic environment is conserved in both complexes
even though the sidechains concerned are not strictly the
same. Surprisingly, the specific hydrogen bonds found in
the S100C as well as the p11 complex involve conserved
Glu residues in these two S100 proteins. Glu13 in S100C
(Glu9 in p11) makes hydrogen bonds with the peptide
backbone and Glu9 (Glu5 in p11) makes a hydrogen bond
with the sidechain of residue 4 in the peptide, which is a
hydrogen bond donor in both cases (Ser4 in the N terminus
of annexin I and His4 in the N terminus of annexin II). 
These equivalent hydrogen bonds cannot carry the speci-
ficity of recognition, yet the complexes of S100C and p11
with their respective annexin ligands are very specific.
Experiments that have identified S100C as the ligand of
the N terminus of annexin I have not revealed the pres-
ence of p11, and when annexin II is purified from tissue,
it is found complexed only with p11 and never with
S100C. Moreover, liposome co-pelleting experiments
give no indication of an interaction between S100C and
annexin II or between p11 and annexin I (JS and VG,
unpublished results). To address this issue directly we
have carried out ‘cross-interaction’ experiments in which
we have analysed the interaction of p11 with the annexin
I N-terminal peptide and the interaction of S100C with a
fluorescence-labelled annexin II N-terminal peptide.
The results, summarised in Figure 4, show that blue
shifts in the fluorescence emission of the Prodan-labelled
annexin II peptide (Ac1–14), or the tryptophan-contain-
ing annexin I peptide (Ac1–18) are observed only when
the correct binding partner is present. In contrast, no
blue shift indicative of the protein−peptide interaction
occurs when S100C is added to Prodan-labelled Ac1–14,
or when p11 is added to the Ac1–18 peptide. We also per-
formed competition experiments by adding increasing
amounts of S100 proteins or peptides to preformed com-
plexes and recording the respective emission spectra.
Figure 5 clearly reveals that no red shift in the emission
maximum indicative of a release of the fluorescent
peptide from its S100 binding partner is observed. The
slight decrease in fluorescent emission intensity is non-
specific and is also seen when the peptides are added in
their non-acetylated (therefore binding-incompetent)
form. These data show that complexes formed between
S100C and Ac1–18 and between p11 and Ac1–14 are
indeed specific and that the partners cannot substitute
for one another. The reason for this specificity, which is
not evident from the hydrogen- bonding patterns seen in
the crystal structures, may lie in the overall characteristics
of the two complexes; the interaction interfaces are sys-
tematically smaller for the S100C–annexin I peptide
complex than for the p11–annexin II peptide complex,
with dimer interfaces of 2020 Å2 and 2420 Å2, respec-
tively. Similarly, the peptide–protein interface is 1920 Å2
for the S100C–annexin I complex and 2260 Å2 for the
p11–annexin ΙΙ complex, and 880 Å2 of the annexin I
peptide are buried as opposed to 1110 Å2 for the annexin
II peptide (the buried surfaces were calculated using the
Connolly algorithm [42]). Thus, it appears that the
p11–annexin II complex could be more stable than the
S100C–annexin I complex and, furthermore, that the
S100C dimer may be less stable than the p11 dimer,
further contributing to differences in S100-target
complex stability.
The close similarity of the two structures extends to the
EF hands, which differ the most in sequence. In p11, both
EF-hand sequences are such that neither can bind
calcium, yet the conformation of the backbone is very
close to that of Ca2+-loaded EF hands [32]. S100C is very
closely related to p11, but its EF hands bind calcium ions
normally. The extremely close correspondence of the
backbones of the entire proteins shows that the mutated
EF hands in p11 have retained perfectly the folding of a
calcium-loaded S100 protein.
Furthermore, the close similarity of the two structures
suggests that they represent a general mode of interaction
of S100 proteins with their target peptides. This correlates
well with the results from solution studies of S100B with
CapZ and p53 peptides [15,43], which have identified
similar regions of interaction on the S100B molecule.
Biological implications
Annexin I is well known as a substrate for the epidermal
growth factor (EGF) receptor kinase [44]. In fibroblasts
that express the EGF receptor kinase, annexin I has 
been localised to multivesicular endosomes, endocytotic
organelles implicated in the sorting of the internalised
EGF receptor [27]. Annexin I is phosphorylated by the
internalised receptor in or at the multivesicular endo-
somes and this regulatory event is thought to participate
in the inward vesiculation process that targets inter-
nalised receptors to the degradative pathway [27]. At
some point the inward budding of the limiting endosomal
membrane could depend on, or be facilitated through, the
formation of heterotetrameric annexin I–S100C com-
plexes which would link two membrane-binding annexin
I entities. Mechanistically, this activity would be similar to
the annexin II–p11 heterotetramer formation implicated
in Ca2+-regulated exocytosis [2]. In contrast to annexin
II−p11, however, complex formation of annexin I and
S100C is Ca2+-regulated and it is not clear whether and
how Ca2+ is involved in regulating the endocytotic events
described. Moreover, although annexin I has been shown
to target S100C to endosomal membranes in certain types
of cells [28], it is not known whether a heterotetrameric
annexin I–S100C complex forms as a functionally impor-
tant unit on endosomes. A number of other intracellular
activities, including an involvement in the transduction of
mitogenic signals, are discussed for annexin I [45] but
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S100C has not been implicated in the regulation of such
activities.
The S100C protein, and annexin I, have recently been
detected in the cornified envelope of keratinocytes, in
which both of them undergo crosslinking by transgluta-
minases [24,25]. It it not unreasonable to speculate that
an annexin I–S100C complex forms during the differen-
tiation of these cells and participates in the formation of
the crosslinked protein structures. The three-dimen-
sional structure of the S100C–annexin I N-terminal
peptide complex presented here could be relevant to the
formation of such complexes as we found a disulphide
bridge linking the monomers of the S100C dimer, a sta-
bilising feature that could be of importance in the estab-
lishment of scaffolding structures. It should be noted,
however, that due to disorder, our structure does not
show the N-terminal extremity of S100C implicated in
the transglutaminase crosslink [25].
The formation of disulphide bridges in S100 proteins is
still subject to controversy [40]. Indeed some members
of the S100 family are found in the extracellular, oxidis-
ing, milieu. For example, S100B, the neurite extension
factor (NEF) [36–38,46], induces neurite extension in
its oxidised form [38], glial proliferation [46] or neuronal
death [47], whereas S100A8 (MRP8) possesses chemo-
tactic activity which is down-regulated by covalent
disulphide-dependent dimerisation [48]. Nevertheless,
most S100 proteins appear to function as intracellular
calcium-modulated proteins that might regulate diverse
functions including cell growth, differentiation, energy
metabolism, cytoskeleton−membrane interactions and
kinase activities [10]. A possible disulphide-dependent
dimerisation of intracellular cytosolic proteins could
occur in some physio-pathological situations, such as
the oxidative response occurring during inflammation in
phagocytes, as has been shown to occur in bacteria as a
response to stress [49].
Materials and methods
Purification, crystallisation and data collection
Porcine S100C was expressed in E. coli and purified as described previ-
ously [22]. The annexin I N-terminal peptide Ac-AMVSEFLKQAWFIE was
synthesised by Neosystem (Strasbourg). Purified S100C and peptide
were mixed in quantities ensuring a slight excess of peptide, then dial-
ysed against 50 mM Tris-HCl, 10 mM CaCl2, pH 7.5 and finally concen-
trated by ultrafiltration to 20 mg/ml. Because there is only one tryptophan
in the peptide and none in S100C, the complex formation was monitored
by absorbance at 280 nm. Crystals were grown by the vapour diffusion
method using hanging drops with a 1:1 ratio of protein solution and
reservoir solution consisting of 20% polyethylene glycol (PEG) 4000,
10% 2-propanol, 100 mM HEPES, pH 8.5. Data were collected at LURE
on beamline D41 (wavelength 1.37 Å) and complete data sets of crystals
cooled to 16°C were recorded on a MAResearch area detector. Crystals
belong to space group P6122 with cell dimensions a = b = 77.5 Å,
c = 111.6 Å. Data were processed using DENZO [50]. Because of sig-
nificant decay only the first frames of several data sets were scaled
together with SCALA [51] to produce a unique complete data set (Table
1). Though crystals were quite large (0.8 mm × 0.4 mm × 0.4 mm), dif-
fraction falls off beyond 2.4 Å. With one complex of S100C−peptide in
the asymmetric unit, the VM [52] is 3.9, corresponding to 68.2% solvent.
This high solvent content may explain the limited diffraction observed. 
Structure solution and refinement
The structure was solved by molecular replacement with AMoRe using
the structure of apo p11 (PDB entry 1A4P) as a starting model. Only
one position for the S100C monomer was found in the asymmetric
unit. The structure was refined by rigid body refinement and energy
minimisation using X-PLOR [53]. The peptide was constructed in a
Fo–Fc difference Fourier map using O [54]. Further refinement was
carried out with REFMAC [51]. The disulphide bond, which lies across
a twofold crystallographic axis, was not refined but the van der Waals
radius of the sulphur atom of Cys11 was reduced to allow a correct
geometry for the disulphide bridge.
Fluorescence spectroscopy of S100–peptide complexes
The interaction between S100C or p11 with different acetylated and non-
acetylated annexin peptides was analysed by fluorescence spectroscopy.
Peptides corresponding to the N-terminal 18 residues of human
annexin I (sequence: AMVSEFLKQAWFIENEEQ) containing an N-ter-
minal acetyl group (Ac1–18) were synthesised by Interactiva Biotech-
nology GmbH (Ulm, Germany), whereas the unmodified form (N1–18)
was prepared as described previously [41]. Peptides corresponding to
the 14 N-terminal residues of human annexin II (sequence: STVHEIL-
CKLSLEG) in N-terminally acetylated (Ac1–14) and unmodified
(N1–14) form were synthesised as described previously [55]. Prodan
modification of the single cysteine residue at position 8 of Ac1–14 was
carried out for 2 h at 25°C in PBS with a tenfold molar excess of
Prodan (Molecular Probes). Prodan-modified Ac1–14 was then puri-
fied by reverse-phase HPLC as described previously [56].
For binding studies involving the annexin II peptide, 1 µM Prodan-
labelled Ac1–14 in 50 mM imidazole, pH 7.5, 150 mM NaCl and
0.2 mM EGTA was excited at 392 nm (4 nm bandwidth) and the fluo-
rescence emission spectrum of the free peptide was recorded between
400 and 650 nm (4 nm bandwidth) on a FluoMax-2 spectrofluorimetre
from Jobin Yvon Spex. Subsequently, purified S100C or p11 [22,32]
dialysed against the same buffer were added and the emission spec-
trum of the Prodan group was recorded. Binding studies involving the
annexin I peptide Ac1–18 made use of the sole tryptophan at position
11. 10 µM Ac1–18 in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl and
0.2 mM EGTA were excited at 295 nm (4 nm bandwidth) either alone or
in the presence of purified S100C or p11 dialysed against the same
buffer. Emission spectra were then recorded between 310 and 500 nm
(4 nm bandwidth). Titration experiments employed the amounts of S100
proteins given in the figure legends. Peptide and protein concentrations
were determined routinely using OD230 readings. In some experiments
the non-acetylated variants of the peptides were used as negative con-
trols. Analysis of peptide fluorescence in the presence of S100C was
carried out after addition of 0.5 mM CaCl2, whereas experiments in the
presence of the Ca2+ insensitive protein p11 were carried out in the
corresponding Ca2+-free buffer.
Accession numbers
The coordinates and structure factors of the complexes have been
deposited with the PDB, ID numbers 1QLS and R1QLSSF respectively.
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